AGP Picks
View all

Essential Healthcare News
Provided by AGP

Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 13, 2026

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
May 13, 2026

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences

Indeterminate GlobeNewswire
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
May 13, 2026

INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

Indeterminate GlobeNewswire
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
May 13, 2026

ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial

Indeterminate GlobeNewswire
Abacus Global Management to Participate in the 26th Annual B. Riley Investor Conference
May 13, 2026

Abacus Global Management to Participate in the 26th Annual B. Riley Investor Conference

Indeterminate GlobeNewswire
Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
May 13, 2026

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Indeterminate GlobeNewswire
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
May 13, 2026

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire
Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
May 13, 2026

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

Indeterminate GlobeNewswire
ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
May 13, 2026

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President

Indeterminate GlobeNewswire
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
May 13, 2026

Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus

Indeterminate GlobeNewswire
Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药
May 13, 2026

Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药

Indeterminate GlobeNewswire
Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗，已為首位患者完成給藥
May 13, 2026

Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗，已為首位患者完成給藥

Indeterminate GlobeNewswire
InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026

InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor

Indeterminate GlobeNewswire
BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
May 13, 2026

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Dyne Therapeutics to Participate in Upcoming Investor Conferences
May 13, 2026

Dyne Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
May 13, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 13, 2026

Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update

Indeterminate GlobeNewswire
Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
May 13, 2026

Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market

Indeterminate GlobeNewswire
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 13, 2026

BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Indeterminate GlobeNewswire
Altimmune Announces First Quarter 2026 Financial Results and Business Update
May 13, 2026

Altimmune Announces First Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Essential Healthcare News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.